The role of chemotherapy for metastatic melanoma

Bookmark and Share
Published: 26 Sep 2016
Views: 1618
Prof Paul Lorigan - University of Manchester, Manchester, UK

Prof Lorrigan speaks with ecancertv at WCCS 2016 about the changing role of chemotherapy for metastatic melanoma.

Given the emergence of alternative therapies, he considers which tumour types and patient subgroups may be more or less responsive, and how to take chemotherapy into a changing field of targeted and combination therapies.

He also comments on the accelerated response of some patients, as discussed by Dr Dirk Schadendorf here.

ecancer's filming at WCCS 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.